Relmada Therapeutics (RLMD) Cash from Investing Activities (2014 - 2026)
Relmada Therapeutics (RLMD) reported Cash from Investing Activities of $17.59 million for Q2 2026, up 163.3% from $6.68 million a year earlier.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Cash from Investing Activities (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Relmada Therapeutics' Cash from Investing Activities came in at -$187.82 million; for FY2025, it was -$48.14 million.
- By year, Cash from Investing Activities came in at $51.56 million in FY2024 (+2.2%), $50.45 million in FY2023 (+155.7%), $19.73 million in FY2022 and -$54.12 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Cash from Investing Activities since Q1 2023.
- Year over year, Cash from Investing Activities gained in four of the last six quarters, with growth averaging 78.4%.
- The high point for year-over-year Cash from Investing Activities in five years was Q3 2021 (growth of 499.7%); the low point was Q3 2023 (a decline of 87.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at -$135.23 million (Q1 2026), -$76.93 million (Q4 2025) and $6.75 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Relmada Therapeutics | 384.01 Mn | 384.01 Mn | - | 17.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.59 Mn |
| Mar 31, 2026 | -135.23 Mn |
| Dec 31, 2025 | -76.93 Mn |
| Sep 30, 2025 | 6.75 Mn |
| Jun 30, 2025 | 6.68 Mn |
| Mar 31, 2025 | 15.36 Mn |
| Dec 31, 2024 | 11.35 Mn |
| Sep 30, 2024 | 16.14 Mn |
| Jun 30, 2024 | 14.01 Mn |
| Mar 31, 2024 | 10.06 Mn |
| Dec 31, 2023 | 7.74 Mn |
| Sep 30, 2023 | 3.86 Mn |
| Jun 30, 2023 | -1.15 Mn |
| Mar 31, 2023 | 40.00 Mn |
| Dec 31, 2022 | -1.66 Mn |
| Sep 30, 2022 | 31.56 Mn |
| Jun 30, 2022 | -140,520.00 |
| Mar 31, 2022 | -10.03 Mn |
| Dec 31, 2021 | -91.18 Mn |
| Sep 30, 2021 | 27.51 Mn |
API Access
Relmada Therapeutics Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();